化学反应取代了全活性CTL中的杀死反应,在细胞排斥过程中提供了血管免疫特权
Thomas Barba1,2,3, Martin Oberbarnscheidt4, Gregory Franck5
1CIRI, INSERM U1111, Université Claude Bernard Lyon I, CNRS UMR 5308, Ecole Normale Supérieure de Lyon, Université de Lyon, Lyon, France.
The Journal of clinical investigation
|May 28, 2025
概括
移植内皮细胞在T细胞中介排斥 (TCMR) 过程中不受免疫攻击,而不是通过内在的抵抗,而是通过转移细胞毒性T淋巴细胞 (CTLs) 从血管向上皮细胞目标的树皮细胞信号.
科学领域:
- 免疫学 免疫学 免疫学
- 移植生物学 移植生物学
- 血管生物学 血管生物学
背景情况:
- 移植内皮细胞 (ECs) 表达异位抗原,并在T细胞介导排斥 (TCMR) 过程中被细胞毒性T淋巴细胞 (CTLs) 准.
- 尽管如此,ECs通常是幸免的,而上皮结构主要受到影响,这种现象被称为血管免疫特权.
- 这种保护的基本机制仍然不太清楚.
研究的目的:
- 阐明在TCMR过程中负责保护移植内皮细胞的机制.
- 调查EC保护是细胞内在的还是细胞外在的.
- 确定化疗在调解血管免疫特权中的作用.
主要方法:
- 转录组学分析和内皮 - 介质细胞过渡评估.
- 用EC,上皮细胞和CTL进行共培养实验.
- 内显微镜对小鼠脏移植和单细胞RNA-Seq对人类脏全移植进行检查.
- 实验室化疗检测和对TCMR患者活检的分析.
主要成果:
- 转录组学和EMT评估证实了TCMR期间的EC保存.
- 共同培养实验表明,EC和上皮细胞对CTL溶解具有相似的敏感性,排除了细胞内在的保护.
- 肠道显微镜和单细胞RNA-Seq揭示了与CTL-表皮细胞相互作用相比,短暂的CTL-EC相互作用.
- 鉴定出了来自移植 stromal 细胞的化疗梯度,引导 CTL 远离 EC 转向上皮细胞标,覆盖细胞毒性.
- 在TCMR活检中破坏这种化疗梯度与内皮炎相关,表明血管损伤.
结论:
- 在TCMR中,血管免疫特权是由细胞外部机制调解的,它涉及化学反应,而不是细胞内部的保护.
- 流体细胞衍生的化疗梯度重定向CTL,保持移植血管结构.
- 这种通过化学反应介导的机制对于在TCMR期间维持血管完整性至关重要,并且可能对其他病理状况产生更广泛的影响.
相关概念视频
Cytotoxic T Cells-mediated Immune Response
2.6K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.6K
Cell-mediated Immune Responses
74.3K
Overview
74.3K
Chemotaxis and Direction of Cell Migration
3.6K
Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon...
3.6K
Special Features of Adaptive Immunity
1.2K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
1.2K
Cells of the Innate Immune Response
3.9K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
3.9K
Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675


